Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 8384
  • Home
  • Print this page
  • Email this page

    Article Cited by others

SYMPOSIUM

A comparative debate on the various anti-vascular endothelial growth factor drugs: Pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin)

Nagpal Manish, Nagpal Kamal, Nagpal P N

Year : 2007| Volume: 55| Issue : 6 | Page no: 437-439

   This article has been cited by
 
1 Neuropeptides and diabetic retinopathy
Robert Gábriel
British Journal of Clinical Pharmacology. 2013; 75(5): 1189
[Pubmed]  [Google Scholar] [DOI]
2 Vitreous and serum levels of vascular endothelial growth factor and platelet-derived growth factor and their correlation in patients with non-proliferative diabetic retinopathy and clinically significant macula oedema
Anna Praidou, Eleni Papakonstantinou, Sofia Androudi, Nikolaos Georgiadis, George Karakiulakis, Stavros Dimitrakos
Acta Ophthalmologica. 2011; 89(3): 248
[HTML Full text]  [Google Scholar] [DOI]
3 Sodium pegaptanib and ranibizumab in the treatment of the retinal pigment layer ablation in a patient with age-related macular degeneration - A case report | [Pegaptanib sodný a ranibizumab v léčbě ablace pigmentového listu sítnice u pacienta s věkem podmíněnou makulární degenerací- Kazuistika]
Šín, M., Šimičák, J., Prachařová, Z., Řehák, J.
Ceska a Slovenska Oftalmologie. 2010; 66(3): 138-141
[Pubmed]  [Google Scholar]
4 Association of vascular endothelial growth factor -634C/G polymorphism and diabetic retinopathy in type 2 diabetic Han Chinese
Yang, Y., Andresen, B.T., Yang, K., Zhang, Y., Li, X., Li, X., Wang, H.
Experimental Biology and Medicine. 2010; 235(10): 1204-1211
[Pubmed]  [Google Scholar]
5 Bevacizumab and ranibizumab on microvascular endothelial cells: A comparative study
Raquel Costa, Ângela Carneiro, Ana Rocha, Ana Pirraco, Manuel Falcăo, Luísa Vasques, Raquel Soares
Journal of Cellular Biochemistry. 2009; 108(6): 1410-1417
[Pubmed]  [Google Scholar] [DOI]
6 Intravitreal ranibizumab (Lucentis{\textregistered}) for the treatment of myopic choroidal neovascularization
Konstantinidis, L. and Mantel, I. and Pournaras, J.A.C. and Zografos, L. and Ambresin, A.
Graefećs Archive for Clinical and Experimental Ophthalmology. 2009; 247(3): 311-318
[Pubmed]  [Google Scholar]
7 Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice
Liu, T.-G., Huang, Y., Cui, D.-D., Huang, X.-B., Mao, S.-H., Ji, L.-L., Song, H.-B., Yi, C.
BMC Cancer. 2009; 9(Art 250)
[Pubmed]  [Google Scholar]
8 Effects of Anti-Vascular Endothelial Growth Factor (VEGF) on Pancreatic Islets in Mouse Model of Type 2 Diabetes Mellitus
Ji-Won Kim,Dong-Sik Ham,Heon-Seok Park,Yu-Bai Ahn,Ki-Ho Song,Kun-Ho Yoon,Ki-Dong Yoo,Myung-Jun Kim,In-Kyung Jeong,Seung-Hyun Ko
Korean Diabetes Journal. 2009; 33(3): 185
[Pubmed]  [Google Scholar] [DOI]
9 Recent progress in macular function self-assessment
Richard Trevino
Ophthalmic and Physiological Optics. 2008; 28(3): 183
[Pubmed]  [Google Scholar] [DOI]
10 Recent progress in macular function self-assessment.
Trevino, R.
Ophthalmic \& Physiological Optics. 2008; 28(3): 183-192
[Pubmed]  [Google Scholar]
11 Debate on the various anti-vascular endothelial growth factor drugs
Khalili, M.R. and Hosseini, H.
Indian Journal of Ophthalmology. 2008; 56(3): 255-256
[Pubmed]  [Google Scholar]
12 Author′s reply
Nagpal, M., Nagpal, K., Nagpal, P.N.
Indian Journal of Ophthalmology. 2008; 56(3): 256
[Pubmed]  [Google Scholar]
13 Current status of development of anticancer agents in Japan
Morita, T. and Hori, A. and Narimatatsu, H. and Tanimoto, T. and Kami, M.
International Journal of Hematology. 2008; 87(5): 484-489
[Pubmed]  [Google Scholar]
14 Current status of development of anticancer agents in Japan
Tomohiro Morita,Akiko Hori,Hiroto Narimatatsu,Tetsuya Tanimoto,Masahiro Kami
International Journal of Hematology. 2008; 87(5): 484
[Pubmed]  [Google Scholar] [DOI]

 

Read this article